Sinovac Acquires New Manufacturing Facility

Sinovac Biotech (北京科兴生物制品有限公司) has acquired a medical manufacturing site and land use rights in the Changping area of Beijing. The site, which includes five buildings previously used to produce medical products, is about a half-hour’s drive from Sinovac’s existing Beijing facility. Sinovac will pay 120 million RMB ($17.6 million), of which 56.5 million RMB ($8.3 million) is due before February 20, 2010 with the balance to be paid over three years. More details... Stock symbols: (NSDQ: SVA)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.